An ERA, or endometrial receptivity analysis, is a genetic test used during IVF to determine whether your uterine lining is ready to receive an embryo at the time a transfer would normally be scheduled. It analyzes the activity of 238 to 248 genes in a small tissue sample from your uterus, then uses a computational model to predict whether your implantation window is on schedule, early, or late. The goal is to personalize the timing of your frozen embryo transfer so the embryo arrives when your body is most likely to accept it.
How the Test Works
Your uterine lining goes through a brief period of receptivity each cycle, often called the “window of implantation.” In a standard frozen embryo transfer, your doctor assumes this window opens at a predictable time after you start progesterone. The ERA test checks whether that assumption holds true for you specifically.
The test uses a technology called transcriptomics, which measures the activity levels of genes in your tissue. By comparing the gene expression pattern in your biopsy to a database of known receptive and non-receptive profiles, the test classifies your endometrium into one of several categories: receptive, pre-receptive, post-receptive, or late receptive. Each result comes with a specific recommendation for how to adjust the timing of your embryo transfer.
What the Biopsy Involves
The ERA requires an endometrial biopsy, a quick in-office procedure where a thin catheter is passed through your cervix to collect a small sample of uterine lining tissue. It’s done during a “mock cycle,” meaning you go through the same hormonal preparation you’d use for a real frozen embryo transfer but no embryo is actually placed.
In a typical hormone replacement protocol, you start taking estrogen early in your cycle for roughly two weeks until your lining reaches adequate thickness (at least 8 mm on ultrasound). Then you begin progesterone, and the biopsy is performed after several days of progesterone exposure, usually between days 3 and 7. This timing matters because the test needs to capture your endometrium during the window when it would normally become receptive.
The biopsy itself takes a few minutes and can cause cramping similar to a period. The tissue sample is sent to a lab, and results typically come back within a couple of weeks.
Understanding Your Results
If your result comes back as “receptive,” it means your implantation window lines up with the standard transfer timing. No changes are needed, and your embryo transfer can proceed on a normal schedule.
A “pre-receptive” result means your window hasn’t opened yet at the time of biopsy, so your lining needs more progesterone exposure before transfer. Your doctor would delay the transfer by a day or more in a future cycle. A “post-receptive” result means the window has already passed, indicating your lining becomes ready earlier than expected. In that case, the transfer would be moved earlier, sometimes by 24 hours or more.
Some results fall in between, like “late receptive,” which calls for fine-tuned adjustments. In one published case, a patient who received a late receptive result was advised to transfer her embryo at 67 hours of progesterone exposure rather than the standard timing. Getting to the right window sometimes requires more than one biopsy cycle, particularly in complex cases where the initial adjustment doesn’t fully capture the receptive phase.
Who Gets Recommended for ERA
The ERA test is most commonly discussed for patients with repeated implantation failure, meaning they’ve had multiple embryo transfers with good-quality embryos that didn’t result in pregnancy. The logic is straightforward: if the embryos look healthy but aren’t implanting, perhaps the timing is off rather than the embryo quality.
Some clinics also offer ERA as part of a broader panel. Two related tests, EMMA and ALICE, can be performed from the same biopsy sample. EMMA (Endometrial Microbiome Metagenomic Analysis) profiles the bacteria living in the uterus, checking whether beneficial Lactobacillus species make up at least 90% of the microbial community. ALICE (Analysis of Infectious Chronic Endometritis) specifically screens for bacteria known to cause chronic uterine inflammation. When these tests detect an imbalance or infection, targeted treatment with antibiotics or probiotics can be given before the embryo transfer.
What the Evidence Shows
The clinical evidence on ERA is more nuanced than many fertility clinics convey. A large randomized trial published in JAMA compared ERA-guided frozen embryo transfers to standard-timing transfers in patients who had genetically normal (euploid) embryos. The live birth rate was 58.5% in the ERA group and 61.9% in the standard timing group. The difference was not statistically significant, meaning the ERA test did not improve outcomes in this population.
This is an important finding because it suggests that for the general IVF population, particularly those with good-quality embryos who haven’t experienced repeated failures, the standard timing works well enough. Most people’s implantation windows do fall within the expected range.
Where the picture gets more complicated is in patients with repeated implantation failure. Proponents argue that this is precisely the group most likely to have a displaced window, and that broad trials dilute the signal by including too many patients whose timing was already correct. Some smaller studies and case reports show striking results in individual patients whose windows turned out to be significantly shifted. However, large, rigorous trials confirming a benefit specifically in the repeated failure population are still limited.
Cost and Practical Considerations
An ERA test typically costs between $600 and $1,000 for the test itself, with additional costs for the mock cycle medications and monitoring appointments. Insurance rarely covers it. Because it requires a full mock cycle, it also adds roughly one month to your treatment timeline before you can proceed with an actual embryo transfer.
If the first biopsy comes back non-receptive and your doctor adjusts the timing, some patients need a second biopsy in another mock cycle to confirm the new timing is correct. This can add another month and another round of costs. For patients who’ve already been through multiple failed transfers, the time and expense can feel significant, but so can the possibility of finally getting the timing right.
The test is most useful when there’s a genuine clinical puzzle: your embryos are chromosomally normal, your lining looks good on ultrasound, and transfers keep failing without an obvious explanation. In that scenario, identifying a shifted implantation window is one of the few actionable findings that can change your protocol in a concrete way.